InsiderTrades

Ragosa Mark

SEC CIK 1835458 · EDGAR

Buying vs selling by month open-market trades, last 33 months, KNSA
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
KNSAKiniksa Pharmaceuticals International, plcCFO 25.3K — $12.46M 702022-03-162026-09-01

Most active insiders at KNSA, 12 months

#InsiderTitleBoughtSold
1 Patel Sanj KCOB, CEO, Dir —$39.43M
2 Paolini John F.Chief MEDICAL Off —$8.00M
3 Ragosa MarkCFO —$5.56M
4 Tessari EbenChief STRATEGY Off —$3.10M
5 Quart Barry DDir —$2.68M
6 Megna Michael RCAO —$2.64M
7 Cole G BradleyDir —$299.1K
8 Moat RossCOO —$194.5K
9 McCain Tracey LDir ——
10 Levy Richard SDir ——

Transactions 70

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-09-03 16:49 2026-09-01 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +9,104 25.3K +56% —
D 2026-09-03 16:49 2026-09-01 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $79.28 -4,404 20.9K -17% -$349.1K
D 2026-04-08 16:44 2026-04-07 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +2,694 17.5K +18% —
D 2026-04-08 16:44 2026-04-07 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $48.94 -1,303 16.2K -7% -$63.8K
D 2026-04-03 16:40 2026-04-01 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +5,187 17.3K +43% —
D 2026-04-03 16:40 2026-04-01 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $48.13 -2,510 14.8K -15% -$120.8K
DM 2026-03-11 2026-03-09 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $20.69 +36.7K 48.8K +304% +$759.8K
DM 2026-03-11 2026-03-09 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $45.92 -36.7K 30.8K -54% -$1.69M
DM 2026-02-11 2026-02-09 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $43.28 -17.8K 12.1K -60% -$772.3K
DM 2026-02-11 2026-02-09 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $13.87 +10.8K 27.5K +65% +$150.4K
2026-01-09 2026-01-08 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale $41.89 -12.0K 19.1K -39% -$502.7K
DM 2025-12-10 2025-12-08 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $11.34 +42.8K 47.2K +972% +$486.0K
D 2025-12-10 2025-12-08 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $41.49 -42.8K 31.1K -58% -$1.78M
D 2025-11-14 2025-11-12 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $30.93 +19.9K 51.0K +64% +$615.5K
D 2025-11-14 2025-11-12 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $40.94 -19.9K 31.1K -39% -$814.7K
D 2025-10-30 2025-10-28 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $30.93 +100 31.2K +0.3% +$3,093
D 2025-10-30 2025-10-28 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $41.00 -100 31.1K -0.3% -$4,100
DM 2025-09-03 2025-09-01+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +7,897 32.0K +33% —
DM 2025-09-03 2025-09-01+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $33.68 -3,820 31.1K -11% -$128.6K
D 2025-08-06 2025-08-04 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $22.89 +18.9K 45.9K +70% +$432.4K
D 2025-08-06 2025-08-04 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $32.89 -18.9K 27.0K -41% -$621.3K
D 2025-06-05 2025-06-03 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $28.80 -18.3K 27.0K -40% -$527.0K
D 2025-06-05 2025-06-03 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $18.00 +18.3K 45.3K +68% +$329.4K
DM 2025-05-01 2025-04-29+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $16.51 +88.4K 47.0K New +$1.46M
DM 2025-05-01 2025-04-29+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $26.56 -88.4K 27.0K -77% -$2.35M
D 2025-04-29 2025-04-26 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $21.37 -479 27.0K -2% -$10.2K
D 2025-04-29 2025-04-26 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +990 27.5K +4% —
D 2025-04-09 2025-04-07 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +2,694 27.8K +11% —
D 2025-04-09 2025-04-07 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $20.28 -1,303 26.5K -5% -$26.4K
DM 2025-04-03 2025-04-01 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $21.77 -1,617 25.9K -6% -$35.2K
DM 2025-04-03 2025-04-01 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +3,342 25.1K +15% —
D 2025-03-24 2025-03-20 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $12.97 +15.9K 39.3K +68% +$206.8K
D 2025-03-24 2025-03-20 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $23.11 -15.9K 23.4K -41% -$368.5K
DM 2025-03-19 2025-03-16+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $12.97 +21.2K 34.8K +156% +$275.2K
D 2025-03-19 2025-03-16 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $22.61 -448 23.4K -2% -$10.1K
DM 2025-03-19 2025-03-17+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $23.10 -20.3K 23.4K -47% -$469.9K
D 2025-03-14 2025-03-12 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $22.25 -36.4K 23.0K -61% -$809.3K
D 2025-03-14 2025-03-12 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $11.97 +36.4K 59.3K +158% +$435.4K
DM 2024-12-10 2024-12-06+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $11.06 +21.3K 41.8K +103% +$235.2K
DM 2024-12-10 2024-12-06+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $21.34 -27.8K 23.0K -55% -$594.0K
DM 2024-12-05 2024-12-03+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $10.76 +15.1K 24.1K +169% +$162.6K
DM 2024-12-05 2024-12-03+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $21.37 -15.1K 23.0K -40% -$323.0K
DM 2024-09-04 2024-09-01+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $26.74 -3,216 23.0K -12% -$86.0K
DM 2024-09-04 2024-09-01+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +6,305 23.9K +36% —
D 2024-07-25 2024-07-23 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $11.10 +24.2K 43.5K +126% +$269.2K
D 2024-07-25 2024-07-23 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $24.79 -24.2K 19.3K -56% -$601.1K
D 2024-04-30 2024-04-26 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $17.88 -509 19.3K -3% -$9,101
D 2024-04-30 2024-04-26 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +991 19.8K +5% —
D 2024-04-08 2024-04-08 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $17.90 -791 18.8K -4% -$14.2K
D 2024-04-08 2024-04-08 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +2,694 19.6K +16% —
D 2024-04-03 2024-04-01 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +1,750 17.4K +11% —
D 2024-04-03 2024-04-01 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $19.70 -514 16.9K -3% -$10.1K
D 2024-01-04 2024-01-03 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx $8.83 +12.0K 27.6K +77% +$106.0K
D 2024-01-04 2024-01-03 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO S - Sale+OE $20.00 -12.0K 15.6K -43% -$240.0K
DM 2023-09-06 2023-09-01+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $17.76 -1,338 15.6K -8% -$23.8K
DM 2023-09-06 2023-09-01+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +4,556 16.2K +39% —
D 2023-04-28 2023-04-26 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $11.15 -291 12.4K -2% -$3,245
D 2023-04-28 2023-04-26 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +990 12.7K +8% —
D 2023-04-11 2023-04-10 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +2,695 12.5K +27% —
D 2023-04-11 2023-04-10 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $10.71 -791 11.7K -6% -$8,472
DM 2023-03-20 2023-03-16+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +3,030 10.4K +41% —
DM 2023-03-20 2023-03-16+ KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $11.22 -890 9,811 -8% -$9,984
D 2022-09-06 2022-09-02 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $11.44 -547 7,671 -7% -$6,258
D 2022-09-06 2022-09-02 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +1,861 8,218 +29% —
D 2022-04-28 2022-04-26 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +991 6,639 +18% —
D 2022-04-28 2022-04-26 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $9.99 -282 6,357 -4% -$2,817
D 2022-03-23 2022-03-21 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +3,019 6,695 +82% —
D 2022-03-23 2022-03-21 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $10.98 -1,047 5,648 -16% -$11.5K
D 2022-03-18 2022-03-16 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO F - Tax $10.13 -303 3,676 -8% -$3,069
D 2022-03-18 2022-03-16 KNSA Kiniksa Pharmaceuticals International, plc Ragosa Mark CFO M - OptEx — +872 3,979 +28% —

Purchase Sale Sale after option exercise All abbreviations